• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

Research Briefing on Potassium Trifluoro(1-methylnaphthalen-2-yl)boranuide (CAS: 2724247-52-1) in Chemical Biology and Pharmaceutical Applications

Potassium trifluoro(1-methylnaphthalen-2-yl)boranuide (CAS: 2724247-52-1) is an organoboron compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its trifluoroborate moiety and naphthalene backbone, exhibits unique reactivity and stability, making it a valuable intermediate in synthetic chemistry and drug discovery. Recent studies have explored its potential as a building block for bioactive molecules, particularly in the development of kinase inhibitors and other targeted therapeutics.

The compound's structural features, including the electron-deficient boron center and the aromatic naphthalene ring, contribute to its ability to participate in various cross-coupling reactions, such as Suzuki-Miyaura couplings. These reactions are pivotal in the synthesis of complex pharmaceutical agents. A 2023 study published in the Journal of Medicinal Chemistry highlighted the use of Potassium trifluoro(1-methylnaphthalen-2-yl)boranuide in the synthesis of novel PI3K inhibitors, demonstrating its efficacy in enhancing binding affinity and selectivity.

In addition to its synthetic utility, recent research has investigated the pharmacokinetic properties of derivatives derived from this compound. A preclinical study conducted by researchers at the University of Cambridge revealed that the trifluoroborate group improves metabolic stability and membrane permeability, addressing common challenges in drug development. These findings were further supported by computational modeling studies, which predicted favorable interactions with target proteins, such as EGFR and BRAF kinases.

Another area of interest is the compound's potential in boron neutron capture therapy (BNCT), an emerging cancer treatment modality. A 2024 publication in Chemical Science reported that Potassium trifluoro(1-methylnaphthalen-2-yl)boranuide derivatives could serve as effective boron delivery agents due to their high boron content and tumor-targeting capabilities. This application leverages the compound's ability to accumulate selectively in cancer cells, enabling precise radiation therapy with minimal off-target effects.

Despite these advancements, challenges remain in optimizing the compound's solubility and bioavailability. Recent efforts have focused on structural modifications, such as the introduction of hydrophilic substituents, to enhance its pharmaceutical profile. Collaborative research between academia and industry, as documented in a 2023 Nature Communications article, has yielded promising results, with several derivatives advancing to early-stage clinical trials for oncology indications.

In conclusion, Potassium trifluoro(1-methylnaphthalen-2-yl)boranuide (CAS: 2724247-52-1) represents a multifaceted tool in modern drug discovery and chemical biology. Its applications span from synthetic chemistry to targeted therapy, underscoring its importance in the development of next-generation pharmaceuticals. Ongoing research aims to further elucidate its mechanistic roles and expand its therapeutic potential, positioning it as a key player in the field.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)